Asymptomatic infections in blood donors harbouring Plasmodium: an invisible risk detected by molecular and serological tools

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
SIMTI SERVIZI SRL
Autores
CARAMELO, Luiza da Cruz
SANCHEZ, Arianni Rondelli
INOUE, Juliana
COSTA-NASCIMENTO, Maria de Jesus
Citação
BLOOD TRANSFUSION, v.16, n.1, p.17-25, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background. Transfusion-transmitted malaria due to asymptomatic Plasmodium infections is a challenge for blood banks. There is a lack of data on the prevalence of asymptomatic infected blood donors and the incidence of transfusion-transmitted malaria in low endemicity areas worldwide. We estimated the frequency of blood donors harbouring Plasmodium in an area in which asymptomatic infections have been reported. Material and methods. To estimate the frequency of blood donors harbouring Plasmodium we used microscopy and molecular tools. Serological tests were applied to measure the exposure of candidates to Plasmodium antigens. Venous blood was collected from 91 candidates attending the ""Pro-Sangue"" Blood Centre Foundation in Sao Paulo, who lived in the municipality of Juquitiba, Sao Paulo, Brazil, where sporadic autochthonous cases of malaria have been described. Blood samples were used for parasitological, molecular and serological studies. Results. Among the 91 samples examined, rare Plasmodium forms were observed in two donors. Genus real-time polymerase chain reaction analysis demonstrated Plasmodium amplification in three candidates and species-specific nested polymerase chain reaction identified P. malariae in two. ELISA-IgG was reactive in 42.9% of samples for P. vivax (Pv-MSP1 19) and in 6.6% for P. falciparum (Pf-Zw). ELISA-IgM was reactive in 2.2% of samples for P. vivax and in 4.4% for P. falciparum. An indirect immunofluorescence assay was reactive for P. malariae in 15.4% of cases. Discussion. Reservoirs of Plasmodium represent a challenge for blood banks, since studies have shown that high levels of submicroscopic infections can occur in low transmission areas. The risk of transfusion-transmitted malaria presented here points to the need to conduct molecular investigations of candidate donors with any positive malarial antibody test.
Palavras-chave
transfusion-transmitted malaria, blood donors, asymptomatic infection, molecular tools, serological tools
Referências
  1. Assennato SM, 2014, TRANSFUSION, V54, P2419, DOI 10.1111/trf.12650
  2. BRUCECHW.LJ, 1974, B WORLD HEALTH ORGAN, V50, P337
  3. Cerutti C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-33
  4. Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P21, DOI 10.1590/0074-0276140102
  5. Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
  6. Curado I, 1997, MEM I OSWALDO CRUZ, V92, P235, DOI 10.1590/S0074-02761997000200017
  7. de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
  8. FERREIRA AW, 1988, REV I MED TROP, V30, P137, DOI 10.1590/S0036-46651988000300003
  9. Golassa L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1070-1
  10. Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X
  11. Hristov AD, 2014, MEM I OSWALDO CRUZ, V109, P1014, DOI 10.1590/0074-0276140229
  12. Kirchgatter K, 2005, BMJ-BRIT MED J, V331, P576
  13. Kitchen AD, 2014, VOX SANG, V107, P123, DOI 10.1111/vox.12142
  14. Lima GFMC, 2011, MEM I OSWALDO CRUZ, V106, P691, DOI 10.1590/S0074-02762011000600008
  15. Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]
  16. Lima GFMD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150391
  17. Ministerio da Saude do Brasil, 2010, GAZETTE MINISTRY HLT, P35
  18. Ministerio da Saude/Secretaria de Vigilancia em Saude do Brasil, 2005, MAN DIAGN LAB MAL, P166
  19. Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241
  20. Owusu-Ofori AK, 2010, CLIN INFECT DIS, V51, P1192, DOI 10.1086/656806
  21. Reesink HW, 2010, VOX SANG, V98, P468, DOI 10.1111/j.1423-0410.2009.01301.x
  22. Rodrigues MHC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-39
  23. Sanchez AR, 2014, THESIS
  24. Sanchez Maria Carmen Arroyo, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P495, DOI 10.1590/S0036-46651993000600004
  25. Scuracchio P, 2011, REV INST MED TROP SP, V53, P55, DOI 10.1590/S0036-46652011000100010
  26. Seed CR, 2005, TRANSFUS MED REV, V19, P229, DOI 10.1016/j.tmrv.2005.02.004
  27. SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B
  28. Soares IS, 1999, ACTA TROP, V72, P13, DOI 10.1016/S0001-706X(98)00078-3
  29. U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, 2014, GUID IND REC DON QUE
  30. Vinetz JM, 1998, NEW ENGL J MED, V338, P367, DOI 10.1056/NEJM199802053380605
  31. Waltmann A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003758
  32. Wang B, 2014, J CLIN MICROBIOL, V52, P1838, DOI 10.1128/JCM.03615-13
  33. World Health Organization, 2009, MAL MICR QUAL ASS MA, P149